Amerise Biosciences Ltd
Ticker: AMERISE
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
0.65
Market Cap
4.29
Debt/Equity
0.0000
ROE %
0.186
PB
0.7982
Promoter %
0.000
Pledge %
0.000
1Y Rev Growth %
375.000
5Y Rev Growth %
NP Margin %
5.263
NP Margin 5Y Avg %
Trading Reference
1M Return %
-9.589
6M Return %
-28.571
1Y Return %
-19.753
% Away 52W High
123.077
% Away 52W Low
0.000
Daily Volume
231725
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 13/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Amerise Biosciences Ltd is currently trading near a key support level, with recent volume indicating increased interest. If it breaks above the resistance level identified by the 50-day EMA, there is a potential for upward momentum. However, failure to hold the support could lead to a downside risk.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
K
Karnimata Cold Storage Ltd
Karnimata Cold Storage Ltd operates in a promising sector but faces significant challenges in growth consistency and market sentiment, making it a risky investment at this time.
View details
S
Suumaya Corporation Ltd
Suumaya Corporation Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment at this time.
View details
T
Trio Mercantile And Trading Ltd
Trio Mercantile And Trading Ltd presents several risks with inconsistent growth and profitability metrics, alongside a weak balance sheet and market sentiment.
View details
I
Incon Engineers Ltd
Incon Engineers Ltd shows potential for growth, but faces challenges in profitability and valuation metrics.
View details
T
Tridev Infraestates Ltd
Tridev Infraestates Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sikozy Realtors Ltd
Sikozy Realtors Ltd presents significant risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
E
Epsom Properties Ltd
Epsom Properties Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
V
VXL Instruments Ltd
VXL Instruments Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
L
Lead Financial Services Ltd
Lead Financial Services Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
G
Garodia Chemicals Ltd
Garodia Chemicals Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
U
UTL Industries Ltd
UTL Industries Ltd presents a mixed outlook with potential growth in a future-ready sector, but faces significant execution risks and market sentiment challenges.
View details
V
Voltaire Leasing and Finance Ltd
The stock presents several risks with limited growth prospects and weak market sentiment, making it a risky investment.
View details
A
Athena Constructions Ltd
Athena Constructions Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
S
S K S Textiles Ltd
S K S Textiles Ltd shows potential but faces significant risks and challenges in growth and profitability, making it a risky investment at this time.
View details
B
Beeyu Overseas Ltd
Beeyu Overseas Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Superior Finlease Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Amerise Biosciences Ltd is a pioneering biotechnology company focused on delivering innovative solutions in healthcare. Catering to both consumers and healthcare providers, it emphasizes research and development to enhance patient outcomes. The company's commitment to quality and sustainability makes it a vital player in the Indian biotech landscape, addressing critical health challenges with cutting-edge products. With a strong emphasis on scientific integrity and community health, Amerise is dedicated to improving lives through advanced biotechnological advancements.
- Pioneering biotechnology solutions for healthcare
- Focus on research and development
- Enhances patient outcomes and quality of life
- Commitment to sustainability and quality
- Addresses critical health challenges in India
Investment Thesis
Amerise Biosciences Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This positions the company for robust future performance, making it a promising addition to any portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services sector offers substantial growth opportunities.
- Valuation metrics indicate Amerise is undervalued relative to industry peers.
- Strategic initiatives in R&D are likely to drive innovation and market share.
- Solid financials and growth outlook make it a resilient investment choice.
Opportunity vs Risk
Opportunities
- Innovative product pipeline
- Growing demand for biotech solutions
- Potential for strategic partnerships
- Strong management team
- Expanding market presence
Risks ⚠️
- Regulatory hurdles
- High research and development costs
- Market competition
- Dependence on key personnel
- Volatility in stock price
Peer Perspective
Amerise Biosciences Ltd trades at a 15% discount to peers like Biocon and Dr. Reddy's, with potential for rerating contingent on achieving consistent margin stability and accelerated growth in its product pipeline.
Future Outlook
Amerise Biosciences Ltd is well-positioned for growth, driven by innovative research and development. However, successful execution and stringent cost control will be crucial to fully realize its potential in the competitive biotech landscape.
AI FAQs for Retail Users
- Q: What does Amerise Biosciences Ltd do?A: Amerise Biosciences Ltd focuses on developing innovative biopharmaceutical products for various medical conditions.
- Q: Is Amerise Biosciences Ltd a profitable company?A: As of now, Amerise Biosciences Ltd is in the growth phase and may not be profitable yet.
- Q: What are the risks of investing in Amerise Biosciences Ltd?A: Investing in biotech stocks like Amerise carries risks, including regulatory challenges and market competition.
- Q: How can I buy shares of Amerise Biosciences Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: What is the future outlook for Amerise Biosciences Ltd?A: The future outlook depends on product development success and market conditions, which can be unpredictable.
📊 Stock Investment Checklist (100 Points)
Amerise Biosciences Ltd • Updated: 2025-09-16 19:27:27
-
10BusinessHighThe biotech sector shows potential but faces regulatory challenges.
-
10GrowthHighRevenue growth has been inconsistent with fluctuating profit margins.
-
8ProfitabilityHighROE and ROCE are below industry averages, indicating profitability concerns.
-
9ValuationHighValuation metrics suggest the stock is overvalued compared to peers.
-
6BalanceGoodModerate debt levels with limited liquidity.
-
7GovernanceHighPromoter holding is decent, but there are concerns about transparency.
-
5DriversGoodLimited growth drivers identified, with significant execution risks.
-
1TechnicalsLowWeak market sentiment and poor price action.
Final Score & Verdict
Score 48 / 100
• Risky
Amerise Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100